Beacon Pointe Advisors LLC purchased a new stake in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 28,284 shares of the rocket manufacturer's stock, valued at approximately $2,874,000.
Other institutional investors have also recently modified their holdings of the company. BlackRock Inc. purchased a new stake in shares of Rocket Lab during the second quarter worth about $4,124,970,000. Bank of New York Mellon Corp purchased a new position in shares of Rocket Lab during the second quarter valued at approximately $245,764,000. Norges Bank acquired a new stake in Rocket Lab during the fourth quarter worth approximately $341,036,000. Bank of America Corp DE acquired a new stake in Rocket Lab during the second quarter worth approximately $437,280,000. Finally, Alliancebernstein L.P. grew its stake in Rocket Lab by 818.8% in the 3rd quarter. Alliancebernstein L.P. now owns 2,190,132 shares of the rocket manufacturer's stock worth $104,929,000 after acquiring an additional 1,951,755 shares during the period. 71.78% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Rocket Lab news, insider Frank Klein sold 35,558 shares of the company's stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $66.61, for a total value of $2,368,518.38. Following the completion of the transaction, the insider owned 925,737 shares in the company, valued at $61,663,341.57. This represents a 3.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 6,034 shares of the stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $66.65, for a total transaction of $402,166.10. Following the completion of the sale, the senior vice president directly owned 250,917 shares of the company's stock, valued at $16,723,618.05. This trade represents a 2.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 3,524,214 shares of company stock valued at $309,110,848. Company insiders own 8.40% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on RKLB shares. KeyCorp reaffirmed an "overweight" rating on shares of Rocket Lab in a research report on Tuesday, August 11th. TD Cowen raised their price target on Rocket Lab from $90.00 to $120.00 and gave the stock a "buy" rating in a research note on Friday, May 8th. Morgan Stanley restated an "overweight" rating on shares of Rocket Lab in a report on Wednesday, July 8th. New Street Research started coverage on shares of Rocket Lab in a research note on Wednesday, May 13th. They set a "buy" rating and a $150.00 price objective for the company. Finally, Stifel Nicolaus set a $132.00 price objective on shares of Rocket Lab in a report on Thursday, June 4th. Three equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Rocket Lab currently has a consensus rating of "Moderate Buy" and an average target price of $110.65.
Read Our Latest Report on Rocket Lab
Rocket Lab Stock Down 4.6%
RKLB opened at $64.39 on Friday. The firm has a 50 day moving average price of $77.80 and a 200 day moving average price of $84.98. The company has a market cap of $38.53 billion, a PE ratio of -238.47 and a beta of 2.60. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Sell-side analysts expect that Rocket Lab Corporation will post -0.2 earnings per share for the current year.
More Rocket Lab News
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
- Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
- Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
- Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
- Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
- Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.
About Rocket Lab
(
Free Report)
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.